Dexycu Side Effects
Generic name: dexamethasone ophthalmic
Medically reviewed by Drugs.com. Last updated on Jun 1, 2024.
Note: This document provides detailed information about Dexycu Side Effects associated with dexamethasone ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Dexycu.
Applies to dexamethasone ophthalmic: ophthalmic insert extended release, ophthalmic solution, ophthalmic suspension.
Other dosage forms:
Serious side effects of Dexycu
Along with its needed effects, dexamethasone ophthalmic (the active ingredient contained in Dexycu) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking dexamethasone ophthalmic:
More common side effects
- blurred vision
- decreased vision or other changes in vision
- eye pain or redness
- sensitivity of the eye to light
- throbbing pain of the eye
Less common side effects
- loss of vision
- redness of the white part of the eyes or inside of the eyelids
- swelling of the eye
Rare side effects
- burning, dry, or itching eyes
- delayed eye wound healing
- difficulty seeing at night
- discharge, excessive tearing
- eye irritation
- redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
Incidence not known
- difficulty in breathing or swallowing
- drooping of the upper eyelids
- fast heartbeat
- skin itching, rash, or redness
- swelling of the face, throat, or tongue
Other side effects of Dexycu
Some side effects of dexamethasone ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
- headache
Rare side effects
- crusting in the corner of the eye
- feeling of having something in the eye
Incidence not known
- bigger, dilated, or enlarged pupils
- dizziness
For healthcare professionals
Applies to dexamethasone ophthalmic: intraocular implant, intraocular suspension, ophthalmic insert, ophthalmic ointment, ophthalmic solution, ophthalmic suspension.
General adverse events
The most commonly reported side effects were cataract, elevation of intraocular pressure, and conjunctival hemorrhage.[Ref]
Ocular
- Very common (10% or more): Cataract (up to 68%), elevation of intraocular pressure (28%), conjunctival hemorrhage (22%)
- Common (1% to 10%): Eye pain, conjunctival hyperemia, ocular hypertension, reduced visual acuity, conjunctivitis, vitreous floaters, conjunctival edema, dry eye, vitreous detachment, vitreous opacities, retinal aneurysm, foreign body sensation, corneal erosion, keratitis, anterior chamber inflammation, retinal tear, eyelid ptosis, vitreous detachment, keratoconjunctivitis sicca, corneal staining, photophobia, blurred vision, eye pruritus, increased lacrimation
- Rare (less than 0.1%): Burning, stinging
- Frequency not reported: Glaucoma with optic nerve damage, visual acuity and visual field defects, subcapsular cataract formation, secondary ocular infection and perforation of the globe
Postmarketing experience: Complication of device insertion (implant misplacement), device dislocation with or without corneal edema, endophthalmitis, hypotony of the eye (associated with vitreous leakage due to injection), retinal detachment[Ref]
Cardiovascular
- Very common (10% or more): Hypertension (13%)[Ref]
Nervous system
- Common (1% to 10%): Headache
- Uncommon (0.1% to 1%): Dysgeusia, migraine
- Frequency not reported: Dizziness[Ref]
Respiratory
- Common (1% to 10%): Bronchitis[Ref]
Endocrine
- Postmarketing reports: Cushing's syndrome, adrenal suppression
Cushing's syndrome and adrenal suppression may occur at doses higher than recommended in predisposed patients including children and those on CYP P450 3A4 inhibitors.
References
1. (2001) "Product Information. Decadron Ocumeter (dexamethasone ophthalmic)." Merck & Co., Inc
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
4. (2009) "Product Information. Ozurdex (dexamethasone ophthalmic)." Allergan Inc
Frequently asked questions
More about Dexycu (dexamethasone ophthalmic)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic steroids
- Breastfeeding
- En español
Patient resources
Other brands
Ozurdex, Maxidex, Dextenza, Ocu-Dex
Professional resources
Other brands
Related treatment guides
Further information
Dexycu side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.